Market closed
West Pharmaceutical Services/$WST
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About West Pharmaceutical Services
West Pharmaceutical Services is based in Pennsylvania, us, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Ticker
$WST
Sector
Trading on
NYSE
Industry
Life Sciences Tools & Services
Headquarters
Employees
10,600
Website
WST Metrics
BasicAdvanced
$24B
Market cap
49.17
P/E ratio
$6.74
EPS
1.01
Beta
$0.81
Dividend rate
0.25%
Dividend yield
Price and volume
Market cap
$24B
Beta
1.01
52-week high
$413.70
52-week low
$265.00
Average daily volume
561K
Dividend rate
$0.81
Financial strength
Current ratio
3.002
Quick ratio
2.047
Long term debt to equity
10.432
Total debt to equity
11.188
Dividend payout ratio (TTM)
11.73%
Interest coverage (TTM)
118.82%
Management effectiveness
Return on assets (TTM)
10.13%
Return on equity (TTM)
17.78%
Valuation
Price to earnings (TTM)
49.167
Price to revenue (TTM)
8.448
Price to book
8.73
Price to tangible book (TTM)
9.13
Price to free cash flow (TTM)
75.559
Dividend yield (TTM)
0.24%
Forward dividend yield
0.25%
Growth
Revenue change (TTM)
-1.71%
Earnings per share change (TTM)
-9.12%
3-year revenue growth (CAGR)
2.37%
3-year earnings per share growth (CAGR)
-5.80%
3-year dividend per share growth (CAGR)
5.57%
What the Analysts think about WST
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for West Pharmaceutical Services stock.
WST Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
WST Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
WST News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for West Pharmaceutical Services stock?
West Pharmaceutical Services (WST) has a market cap of $24B as of December 22, 2024.
What is the P/E ratio for West Pharmaceutical Services stock?
The price to earnings (P/E) ratio for West Pharmaceutical Services (WST) stock is 49.17 as of December 22, 2024.
Does West Pharmaceutical Services stock pay dividends?
Yes, the West Pharmaceutical Services (WST) stock pays dividends to shareholders. As of December 22, 2024, the dividend rate is $0.81 and the yield is 0.25%. West Pharmaceutical Services has a payout ratio of 11.73% on a trailing twelve-month basis.
When is the next West Pharmaceutical Services dividend payment date?
The next West Pharmaceutical Services (WST) dividend payment date is unconfirmed.
What is the beta indicator for West Pharmaceutical Services?
West Pharmaceutical Services (WST) has a beta rating of 1.01. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.